High Tower Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$13.01 - $27.22 $578,749 - $1.21 Million	-44,485 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $931,515 - $1.22 Million	44,485 New	44,485 $1.08 Million
Q1 2021 May 10, 2021	SELL	$25.02 - $54.99 $124,074 - $272,695	-4,959 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$41.04 - $56.79 $203,517 - $281,621	4,959 New	4,959 $265,000
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $677,282 - $816,689	-29,043 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $469,625 - $795,197	29,043 New	29,043 $776,000
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $138,717 - $222,026	-9,687 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$13.03 - $21.81 $126,221 - $211,273	9,687 New	9,687 $200,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $236,523 - $350,626	-15,695 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $13,032 - $18,751	580 Added 3.84%	15,695 $349,000
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $82,049 - $119,650	3,057 Added 25.35%	15,115 $456,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $6,989 - $9,093	237 Added 2.0%	12,058 $456,000
Q2 2017 Aug 14, 2017	BUY	N/A	11,821	11,821 $330,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.